INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Public company

CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CIK 0001100682

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 1
Max Insider Score15
Connections2with evidence

CRL · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
10
PM
Parisotto Shannon MCEVP, Disc & Safety Assessment
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Option exercise · 10b5-1 plan
M$204K
981 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • ← Insider ofevidence
    Parisotto Shannon MCEVP, Disc & Safety Assessment · Oct 7, 2026
  • ← Lobbied forevidence
    CAPITOL HILL CONSULTING GROUPLDA RR 2026 first quarter · Health issues, FOO, Pharmacy · Aug 26, 2026
7
PM
Parisotto Shannon MCEVP, Disc & Safety Assessment
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Option exercise · 10b5-1 plan
M
—
981 sh
Oct 5, 2026
Oct 7, 2026
traded Oct 5, 2026
+2d
SEC FORM 4

Evidence

15
PM
Parisotto Shannon MCEVP, Disc & Safety Assessment
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Open-market sale · 10b5-1 plan
SELL$303K
981 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

Data sources
SEC FORM 423m ago
HOUSE PTR22m ago
SEC 13F22m ago
ROBINHOOD CHAIN22m ago

Lobbying

$140K reported · de-duplicated
2026 Q2 $70K via firms2026 Q1 $70K via firms
  • CAPITOL HILL CONSULTING GROUP$70K2026 Q2 · posted Aug 26, 2026 · Health issues, FOO, Pharmacy
  • CAPITOL HILL CONSULTING GROUP—2026 Q1 · posted Aug 26, 2026 · Health issues, FOO, Pharmacy
  • CAPITOL HILL CONSULTING GROUP$70K2026 Q1 · posted Aug 26, 2026 · Health issues, FOO, Pharmacy

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.